Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Slideshow
New FDA Warning
Author(s):
A rare but serious reaction to this treatment can have immunological consequences. As with all medications, however, the latest alert does not change how psychiatrists manage the risks.
The new warning for lamotrigine does not change how we manage the risks.
Related Videos
Developing a Small Molecule With Lithium's Benefits, But Not its Baggage: A Conversation With Jonathan M. Meyer, MD, DLFAPA
Insulin Is an Antidepressant: A Conversation With Roger McIntyre, MD, FRCPC
Serious Mental Illness, Substance Use Disorders, and Long-Acting Injectables in the Emergency Setting
Celebrating World Bipolar Day 2025: Best Practices in Treating Bipolar Disorder
Addressing Comorbid Bipolar Disorder and ADHD
The Evolution of Bipolar Disorder Over the Past 40 Years
The Most Common Challenges in Treating Bipolar Disorder
A Patient’s Heroic Journey Continues
Early Intervention Strategies for Bipolar Disorder: Identifying Warning Signs
Clinical Insights Regarding the Management of Bipolar Disorder
Related Content
